MCL coexpression mm9:745
From FANTOM5_SSTAR
Phase1 CAGE Peaks
| Short description | |
|---|---|
| Mm9::chr2:158436467..158436523,+ | p2@Slc32a1 |
| Mm9::chr2:22477648..22477664,+ | p8@Gad2 |
| Mm9::chr2:22477703..22477720,+ | p12@Gad2 |
| Mm9::chr2:22477797..22477823,+ | p2@Gad2 |
| Mm9::chr2:22477867..22477886,+ | p6@Gad2 |
| Mm9::chr2:22477904..22477917,+ | p14@Gad2 |
| Mm9::chr2:22477939..22477950,+ | p13@Gad2 |
| Mm9::chr2:22477966..22477981,+ | p7@Gad2 |
| Mm9::chr2:22477994..22478007,+ | p4@Gad2 |
| Mm9::chr6:138370756..138370767,+ | p@chr6:138370756..138370767 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
| GO ID | GO name | FDR corrected p-value |
|---|---|---|
| GO:0015495 | gamma-aminobutyric acid:hydrogen symporter activity | 0.00380347162330313 |
| GO:0004351 | glutamate decarboxylase activity | 0.00380347162330313 |
| GO:0031410 | cytoplasmic vesicle | 0.00380347162330313 |
| GO:0031982 | vesicle | 0.00380347162330313 |
| GO:0015816 | glycine transport | 0.00380347162330313 |
| GO:0015187 | glycine transmembrane transporter activity | 0.00380347162330313 |
| GO:0005280 | hydrogen:amino acid symporter activity | 0.00380347162330313 |
| GO:0015295 | solute:hydrogen symporter activity | 0.00394423288447031 |
| GO:0015185 | L-gamma-aminobutyric acid transmembrane transporter activity | 0.00394423288447031 |
| GO:0015804 | neutral amino acid transport | 0.005324422636856 |
| GO:0005416 | cation:amino acid symporter activity | 0.00665498125135951 |
| GO:0015175 | neutral amino acid transmembrane transporter activity | 0.00665498125135951 |
| GO:0042136 | neurotransmitter biosynthetic process | 0.00887233581121626 |
| GO:0015179 | L-amino acid transmembrane transporter activity | 0.0145719859665723 |
| GO:0016831 | carboxy-lyase activity | 0.0153732368546372 |
| GO:0005275 | amine transmembrane transporter activity | 0.0177208447861533 |
| GO:0015171 | amino acid transmembrane transporter activity | 0.0177208447861533 |
| GO:0042133 | neurotransmitter metabolic process | 0.0177208447861533 |
| GO:0016830 | carbon-carbon lyase activity | 0.0177208447861533 |
| GO:0015370 | solute:sodium symporter activity | 0.0177208447861533 |
| GO:0006865 | amino acid transport | 0.0177208447861533 |
| GO:0030170 | pyridoxal phosphate binding | 0.0177208447861533 |
| GO:0006836 | neurotransmitter transport | 0.0177208447861533 |
| GO:0015294 | solute:cation symporter activity | 0.0177208447861533 |
| GO:0015837 | amine transport | 0.0177208447861533 |
| GO:0046943 | carboxylic acid transmembrane transporter activity | 0.0177208447861533 |
| GO:0005342 | organic acid transmembrane transporter activity | 0.0177208447861533 |
| GO:0044459 | plasma membrane part | 0.0177208447861533 |
| GO:0046942 | carboxylic acid transport | 0.0177208447861533 |
| GO:0015849 | organic acid transport | 0.0177208447861533 |
| GO:0030424 | axon | 0.0177208447861533 |
| GO:0001505 | regulation of neurotransmitter levels | 0.0243487777157163 |
| GO:0005886 | plasma membrane | 0.0263596127669051 |
| GO:0019842 | vitamin binding | 0.0273307827908039 |
| GO:0043005 | neuron projection | 0.0293224578606538 |
| GO:0015293 | symporter activity | 0.0326705636781114 |
| GO:0016829 | lyase activity | 0.0363096803218342 |
| GO:0048037 | cofactor binding | 0.0390584548816205 |
| GO:0015291 | secondary active transmembrane transporter activity | 0.0398604143884566 |
| GO:0007268 | synaptic transmission | 0.0419391827297904 |
| GO:0019226 | transmission of nerve impulse | 0.0484067856014937 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
| Ontology term | p-value | n |
|---|---|---|
| CNS neuron (sensu Vertebrata) | 1.23e-22 | 23 |
| neuroblast (sensu Vertebrata) | 1.23e-22 | 23 |
| neuron | 4.40e-13 | 33 |
| neuronal stem cell | 4.40e-13 | 33 |
| neuroblast | 4.40e-13 | 33 |
| electrically signaling cell | 4.40e-13 | 33 |
| electrically responsive cell | 8.19e-10 | 39 |
| electrically active cell | 8.19e-10 | 39 |
| neural cell | 3.49e-08 | 43 |
| ectodermal cell | 7.90e-08 | 44 |
| neurectodermal cell | 7.90e-08 | 44 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
| Motifs | -log10(p-value) |
|---|---|
|
{{{tfbs_overrepresentation_jaspar}}} |
